NEWS

August 2024

The National Institute of Health awarded Magnetic Tides two additional supplements to Promote Diversity.

July 2024

Katheryn Thayer-Pham and Cidnee Lu participated in the NYC 2024 Neuromodulation Conference!

They presented exciting new data showing how comfortable kTMP stimulation is at 8 V/m at the cortical level!

They also showed preliminary data on the long lasting effect of kTMP stimulation!

April 2024

Magnetic Tides attended the CNS 2004 Conference in Canada! Philipp Reber, our Lead Neuroscientist, discussed our recent work on kTMP modulating motor performance.

February 2024

Magnetic Tides has been awarded a grant by the Fyssen Foundation to test the use of kTMP to improve speech comprehension. This is a collaboration with Magnetic Tides, UCB and Prof. Benedikt Zoefel from the Centre de Recherche Cerveau et Cognition.

November 2023

Magnetic Tides was chosen as one of Hello Tomorrow’s Deep Tech Pioneers for our innovative brain stimulation device and will be attending Hello Tomorrow Global Summit in March 2024
#DeepTechPioneer #HelloTomorrow

October 2023

CEO of Magnetic Tides, Ludovica Labruna, chats with Michael Waite on his podcast about our innnovative non-invasive brain stimulation device

September 2023

Magnetic Tides' Founders Awarded Weill Neurohub Next Great Ideas Fellowship to use kTMP stimulation to improve motor function in chronic stroke patients.

Collaboration with Dr. Sheltraw and Dr. Labruna from Magnetic Tides, Professor Richard Ivry from UC Berkeley, and Professor Ganguly from UC San Francisco.

August 2023

Magnetic Tides has been awarded by the NIH supplement to promote diversity to enhance the diversity of the research workforce and increase the participation of women and socially and economically disadvantaged individuals in small businesses.

Screen Shot 2022-12-02 at 12.10.22 PM.png

August 2022

Magnetic Tides Awarded by NIH with a Direct Phase 2 SBIR from the National Institute of Neurological Disorders and Stroke (NINDS)

November 2022

Magnetic Tides is Officially an Affiliated Research Institute of the University of California, Berkeley

February 2020

kTMP Has Been Approved as a Non-Significant Risk Device

Find us on social media